Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Novartis
Dow
Chubb
Harvard Business School
Cantor Fitzgerald
Julphar
Citi
Mallinckrodt

Generated: January 19, 2018

DrugPatentWatch Database Preview

Sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sulfacetamide sodium and what is the scope of sulfacetamide sodium freedom to operate?

Sulfacetamide sodium
is the generic ingredient in seventeen branded drugs marketed by Valeant Pharms North, Fougera Pharms, Perrigo Co Tennessee, Taro, Allergan, Alcon, Schering, Pharmafair, Miza Pharms Usa, Akorn, Sola Barnes Hind, Novartis, Optopics, Alcon Pharms Ltd, Bausch And Lomb, and Sandoz Inc, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfacetamide sodium. Twenty-four suppliers are listed for this compound.
Pharmacology for sulfacetamide sodium
Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Medical Subject Heading (MeSH) Categories for sulfacetamide sodium

US Patents and Regulatory Information for sulfacetamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sola Barnes Hind SODIUM SULFACETAMIDE sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 084146-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair SULFAIR-15 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 088186-001 May 25, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Optopics SULFACEL-15 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080024-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Miza Pharms Usa OCUSULF-10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080660-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 078668-001 May 20, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms SULFACETAMIDE SODIUM sulfacetamide sodium LOTION;TOPICAL 077015-001 Nov 17, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alcon CETAMIDE sulfacetamide sodium OINTMENT;OPHTHALMIC 080021-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 089560-001 Oct 18, 1988 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 088947-001 May 17, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmafair SULFAIR 10 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 087949-001 Dec 13, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Medtronic
Argus Health
QuintilesIMS
Federal Trade Commission
Colorcon
Healthtrust
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot